Histopathology of granulomatous liver disease
AASLD LiverLearning®, Jason Lewis, 212276
Early liver transplantation for severe alcoholic hepatitis
AASLD LiverLearning®, Gene Im, 212277
Pro: Patient and allograft survival remain the best metric to gauge successful liver transplantation
AASLD LiverLearning®, John F. Renz, 212278
The link between hepatitis C virus and diabetes mellitus: Improvement in insulin resistance after eradication of hepatitis C virus
AASLD LiverLearning®, Justine Hum, 212279
Transplantation: Loyola university (Con) patient and graft survival outcome at 1 and 3 years posttransplant do not reflect the value of successful liver transplantation
AASLD LiverLearning®, Eric Kallwitz, 212280
Hepatitis C: Who should treat hepatitis C virus? The role of the primary care provider
AASLD LiverLearning®, Tram Tran, 212281
Surgical Risk in the Portal Hypertensive Patient
AASLD LiverLearning®, Prof. Lawrence S. Friedman & Manuel I. Rodriguez-Davalos, 209972
Clinical Liver Disease: Introducing hot topics in hepatology
AASLD LiverLearning®, AASLD, 212270
Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use
AASLD LiverLearning®, Sheila Eswaran, 212271
Problematic lesions in cirrhosis
AASLD LiverLearning®, Alessandro Furlan, 212272
Health literacy and liver disease
AASLD LiverLearning®, Nikolaos Pyrsopoulos, 212273
Pro: Moderate alcohol use is beneficial in nonalcoholic steatohepatitis
AASLD LiverLearning®, Mauricio Lisker, 212274
Arresting frailty and sarcopenia in cirrhosis: Future prospects
AASLD LiverLearning®, Hui-Wei Chen, 212275
Acute on Chronic Liver Failure in Children
AASLD LiverLearning®, Prof. Simon Horslen & Dr. Akash Deep, 208050
Imaging features of hepatic arterial and venous flow abnormalities
AASLD LiverLearning®, Vincent Mellnick, 206009
Clinical studies investigating the effect of vitamin E therapy in patients with NASH
AASLD LiverLearning®, Sebastian Larion, 206010
Review of hepatobiliary contrast agents: Current applications and challenges
AASLD LiverLearning®, Alex Frydrychowicz, 206011
Fontan‐associated liver disease: Monitoring progression of liver fibrosis
AASLD LiverLearning®, Tamir Diamond, 206012
Intra‐arterial locoregional therapy in the management of hepatocellular carcinoma
AASLD LiverLearning®, Anil Seetharam, 206013
Risk factors for progression of and treatment options for NAFLD in children
AASLD LiverLearning®, Phillipp Hartmann, 206014
Use of proton pump inhibitors in chronic liver diseases
AASLD LiverLearning®, Raymond Chung, 206003
Evaluation and management of acute and chronic portal vein thrombosis in patients with cirrhosis
AASLD LiverLearning®, Kellie Young MD, 206004
Management of nosocomial spontaneous bacterial peritonitis: A complex and moving target
AASLD LiverLearning®, Amy G. Ogurick, 206005
Medication nonadherence in liver transplantation
AASLD LiverLearning®, Maureen Whitsett, 206006
A2 liver transplantation across the ABO barrier: Increasing options in the donor pool?
AASLD LiverLearning®, Jin Ge, 206007
Congestive hepatopathy: Differentiating congestion from fibrosis
AASLD LiverLearning®, Alexander Lemmer, 206008
FOLD - Unit 3: Cirrhosis
AASLD LiverLearning®, AASLD, 193367
FOLD - Unit 1: Hepatitis B
AASLD LiverLearning®, AASLD, 193371
FOLD - Unit 2: Hepatitis C
AASLD LiverLearning®, AASLD, 193373
Module 3: Current Management of Portal Hypertension and Variceal Bleeding
AASLD LiverLearning®, Juan G Abraldes, 154427
Module 2: Natural History of Cirrhosis and Management of Compensated Cirrhosis
AASLD LiverLearning®, Guadalupe Garcia-Tsao, 154428
Module 8: Pulmonary Complications in Patients with Cirrhosis
AASLD LiverLearning®, Michael Fallon, 154429
Module 2: Natural History of Cirrhosis and Management of Compensated Cirrhosis (Spanish Version)
AASLD LiverLearning®, Guadalupe Garcia-Tsao, 154430
Module 6: Hepatic Encephalopathy
AASLD LiverLearning®, Jasmohan Bajaj, 154431
Module 7: Bacterial Infections in Cirrhosis with a Focus on Spontaneous Bacterial Peritonitis
AASLD LiverLearning®, Puneeta Tandon, 154432
Module 4: Ascites
AASLD LiverLearning®, Florence Wong, 154433
Module 9: Does My Patient with Cirrhosis Need to be Referred for Liver Transplant?
AASLD LiverLearning®, Paul Martin, 154434
Module 1: Does My Patient Have Cirrhosis?
AASLD LiverLearning®, Patrick Kamath, 154435
Module 5: Hyponatremia and Hepatorenal Syndrome
AASLD LiverLearning®, Thomas Boyer, 154436
Module 3: Current Management of Portal Hypertension and Variceal Bleeding (Spanish Version)
AASLD LiverLearning®, Juan G Abraldes, 154437
Module 1: Hepatitis C Epidemiology and Prevention Globally and for the United States
AASLD LiverLearning®, John Ward, 154442
Module 2: My Patient has Tested Positive for Hepatitis C
AASLD LiverLearning®, Nancy Reau, 154443
Module 3: Assessing severity of liver disease in HCV
AASLD LiverLearning®, Jordan Feld, 154444
Module 4: Management of the Patient with Chronic HCV
AASLD LiverLearning®, Sanjeev Arora, 154445
Module 5: Management of the Chronic HCV Patient with Comorbid and Other Conditions
AASLD LiverLearning®, Raymond Chung, 154446
Module 6: Antiviral treatment of the patient with HCV infection
AASLD LiverLearning®, Michael Fried, 154447
Module 7: Management of Patients with HCV who Have Achieved a Virological
AASLD LiverLearning®, Andrew Muir, 154448
Module 8: The Pediatric patient with HCV
AASLD LiverLearning®, Kathleen Schwarz, 154449
Module 1: HBV: Epidemiology and Screening
AASLD LiverLearning®, Marc Ghany, 154457
Module 2: Patient with positive Hepatitis B serologies
AASLD LiverLearning®, Tram Tran, 154458
Module 3: Natural history of HBV and identification of treatment candidates
AASLD LiverLearning®, Norah Terrault, 154459
Module 4: Management of the Chronic HBV patient with co-morbid and other conditions
AASLD LiverLearning®, Marion Peters, 154460
Module 5: Antiviral treatment of the Patient with Chronic HBV
AASLD LiverLearning®, Anna Lok, 154461
Module 6: Prevention of HBV infection
AASLD LiverLearning®, Brian McMahon, 154462
Module 7: Hepatitis B in the Pediatric Patient
AASLD LiverLearning®, Maureen Jonas, 154463
The gut microbiome and nonalcoholic fatty liver disease
AASLD LiverLearning®, Brian Nadeau, 203819
Primary sclerosing cholangitis: Unique aspects of disease in children
AASLD LiverLearning®, Jillian M. Cotter, 203820
ABO‐incompatible liver transplantation: Is it a viable option with modern innovation?
AASLD LiverLearning®, Abbas Rana, 203821
Pathological patterns of biliary disease
AASLD LiverLearning®, Jason Lewis, 203822
Nonobese nonalcoholic fatty liver disease
AASLD LiverLearning®, sammy saab, 203823
Drug‐drug interactions in hepatitis C virus treatment: Do they really matter?
AASLD LiverLearning®, Paul Kwo, 203824
Controversies in hepatitis C therapy: Reactivation of hepatitis B virus
AASLD LiverLearning®, Michael Fried, 203451
HCV treatment in patients with decompensated liver disease
AASLD LiverLearning®, Elizabeth C. Verna, 203452
Substance use disorders before and after liver transplantation
AASLD LiverLearning®, Jason L. Eccleston, 203453
Nonsurgical options for localized hepatocellular carcinoma
AASLD LiverLearning®, John Willy Haukeland, 203454
Normothermic machine perfusion of the liver
AASLD LiverLearning®, CORRESPONDENCE Garrett R. Roll, 203455
Small‐for‐size syndrome in LT
AASLD LiverLearning®, Taizo Hibi, 203456
Clinical  Hepatology Debrief
AASLD LiverLearning®, Kris Kowdley, 202145
Clinical  Hepatology Debrief: Introduction
AASLD LiverLearning®, Michael Fried, 202146
NAFLD Debrief
AASLD LiverLearning®, Kymberly Watt, 202143
NAFLD Debrief: Introduction
AASLD LiverLearning®, Michael Fried, 202144
Hepatitis Debrief
AASLD LiverLearning®, Paul Kwo, 202141
Hepatitis Debrief: Introduction
AASLD LiverLearning®, Michael Fried, 202142
Leon Schiff SOA: Acute on Chronic Liver Failure
AASLD LiverLearning®, Patrick Kamath, 202139
Leon Schiff SOA: Acute on Chronic Liver Failure: Introduction
AASLD LiverLearning®, Guadalupe Garcia-Tsao, 202140
Postgraduate Course 2017
AASLD LiverLearning®, Session Speakers, 206302
Mayo Spheroid Reservoir Bio-Artificial Liver Improves Survival and Promotes Liver Regeneration in Post Hepatectomy ALF Pigs
AASLD LiverLearning®, Harvey Chen, 201444
Chemical and Toxicology Analysis of Ayurvedic and Herbal Drugs Causing Severe Liver Injury
AASLD LiverLearning®, Cyriac Philips, 201445
Evaluation of spheroid reservoir bioartificial liver with porcine hepatocytes in rhesus monkey model of acute liver failure
AASLD LiverLearning®, YI LI, 201446
Development of a new inhibitory antibody for prevention of HCV infection
AASLD LiverLearning®, Ken Okai, 201447
Human stem cell-derived Encapsulated Mature Liver Tissue as an effective, consistent, and durable in vitro tool for drug testing and development
AASLD LiverLearning®, Massimiliano Paganelli, 201448
The Frequency of Herbal and Dietary Supplement Mislabeling: Experience of the Drug Induced Liver Injury Network
AASLD LiverLearning®, Victor Navarro, 201449
HCV Patient Populations With Challenging Treatment Decisions
AASLD LiverLearning®, Paul Pockros, 202138
Ultrasound-based Elastography for NAFLD
AASLD LiverLearning®, Laurent Castera, 202132
New HCV Therapies in 2017 and Their Impact on Treatment Strategies
AASLD LiverLearning®, Paul Kwo, 202137
Global Perspectives on HCV Eradication
AASLD LiverLearning®, Philippa Easterbrook, 202136
Magnetic Resonance Elastography for NAFLD
AASLD LiverLearning®, Rohit Loomba, 202131
From the AASLD-IDSA Guidance Committee: How We Make Our Recommendations, What Important Gaps Remain in the Care of HCV Patients?
AASLD LiverLearning®, Susanna Naggie, 202135
HCV 2017 Treatment Symposium: Program Chair
AASLD LiverLearning®, Andrew Muir, 202133
Assessing Severity of Portal Hypertension and Prognosis
AASLD LiverLearning®, Massimo Pinzani, 202130
How Accurate is the Diagnosis of Cirrhosis?
AASLD LiverLearning®, Sumeet Asrani, 202129
AASLD/EASL Symposium: Non-invasive Assessment of Liver Disease: Program Chair
AASLD LiverLearning®, Jayant Talwalkar, 202127
Global Forum: The Global Burden of Non-alcoholic Fatty Liver Disease: Closing Remarks
AASLD LiverLearning®, Zobair Younossi, 202124
NAFLD in Children: A Global Perspective
AASLD LiverLearning®, Miriam Vos, 202123
African Content Perspective – AFASLD
AASLD LiverLearning®, Hisham ElKhayat, 202122
South American Perspective – ALEH
AASLD LiverLearning®, Marco Arrese, 202121
Asia-Pacific Perspective – APASL
AASLD LiverLearning®, Barjesh Sharma, 202120
Hans Popper Basic Science SOA: Gut Microbiota and Liver
AASLD LiverLearning®, Bernd Schnabl, 202125
European Perspective – EASL
AASLD LiverLearning®, Frank Tacke, 202119
Hans Popper Basic Science SOA: Gut Microbiota and Liver: Introduction
AASLD LiverLearning®, Gavin Arteel, 202126